S&P 500 7,623.68 −0.52%
Nasdaq 25,955.34 −0.21%
S&P/TSX 35,788.18 −0.52%
Apple 347.73 −0.14%
Nvidia 210.96 −0.59%
Microsoft 524.51 +0.66%
Shopify 236.24 −0.07%
Royal Bank 281.77 −0.36%
CAD/USD 0.7142 +0.01%
AFTER HRS · 18:10 ET
Market ClerkRecap
Fri Oct 23 · after hours6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

GDTC

CytoMed Therapeutics Ltd
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
0.92
+0.00 +0.00%
USD · close Oct 23

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose GDTC in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Choo Chee Kong25.2%
SCHEDULE 13D/A · filed Oct 16 · activist · EDGAR ↗

“Mr. Choo Chee Kong has acquired all of the Ordinary Shares beneficially owned by him (1) in exchange for capital contributions to the Issuer or (2) through public purchases on the open market with his personal funds for investment purposes. The Reporting Person serves as Chairman of the Issuer and i…”

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch GDTC. Know when insiders buy.
One email the day a filing lands. Free.